Gould2: sample sizes

Number of animals tested for each measure in this project, by strain and sex.       Cells with N < 5 are colored pink.


More info about these strains
Gould2 measure Sex 129S6/SvEvTac A/J BALB/cByJ C3H/HeJ C57BL/6J CBA/J DBA/1J DBA/2J
nicotine_acu   plasma nicotine , acute 0.09mg dose   47101 Female
Male 10 10 10 10 10 9 9 10
nicotine_chr   plasma nicotine , chronic 6.3mg dose   47102 Female
Male 10 10 10 10 10 10 10 10
cotinine_acu   plasma cotinine , acute 0.09mg dose   47105 Female
Male 10 10 9 10 10 9 9 9
cotinine_chr   plasma cotinine , chronic 6.3mg dose   47106 Female
Male 10 10 10 10 10 10 10 10
grooming_0   chronic group, grooming , control   47111 Female
Male 10 10 10 10 10 10 10 10
grooming_12   chronic group, grooming , nicotine   47112 Female
Male 10 10 9 10 10 10 10 10
scratching_0   chronic group, scratching , control   47113 Female
Male 10 10 10 10 10 10 10 10
scratching_12   chronic group, scratching , nicotine   47114 Female
Male 10 10 9 10 10 10 10 10
jumping_0   chronic group, jumping , control   47115 Female
Male 10 10 10 10 10 10 10 10
jumping_12   chronic group, jumping , nicotine   47116 Female
Male 10 10 9 10 10 10 10 10
EPM_pct_closed_0   chronic group, time in closed arms , control   47121 Female
Male 10 9 10 10 10 9 7 8
EPM_pct_closed_12   chronic group, time in closed arms , nicotine   47122 Female
Male 10 9 9 10 8 10 7 9
EPM_pct_open_0   chronic group, time in open arms , control   47123 Female
Male 10 9 10 10 10 9 7 8
EPM_pct_open_12   chronic group, time in open arms , nicotine   47124 Female
Male 10 9 9 10 8 10 7 9
EPM_pct_center_0   chronic group, time in center , control   47125 Female
Male 10 9 10 10 10 9 7 8
EPM_pct_center_12   chronic group, time in center , nicotine   47126 Female
Male 10 9 9 10 8 10 7 9
FC_immediate_acu_0   acute group, percent immobility in training chamber after first stimulus pairing , dose control mg   47131 Female
Male 12 11 12 12 14 12 14 12
FC_immediate_acu_045   acute group, percent immobility in training chamber after first stimulus pairing , dose 0.045 mg   47132 Female
Male 10 10 10 9 14 10 14 10
FC_immediate_acu_09   acute group, percent immobility in training chamber after first stimulus pairing , dose 0.09 mg   47133 Female
Male 10 9 10 10 13 8 14 10
FC_immediate_acu_18   acute group, percent immobility in training chamber after first stimulus pairing , dose 0.18 mg   47134 Female
Male 10 10 10 10 14 10 14 10
FC_context_acu_0   acute group, percent immobility in training chamber, 24h after fear conditioning , dose control mg   47136 Female
Male 12 11 12 12 14 12 14 12
FC_context_acu_045   acute group, percent immobility in training chamber, 24h after fear conditioning , dose 0.045 mg   47137 Female
Male 10 10 10 9 14 10 14 10
FC_context_acu_09   acute group, percent immobility in training chamber, 24h after fear conditioning , dose 0.09 mg   47138 Female
Male 10 9 10 10 13 8 14 10
FC_context_acu_18   acute group, percent immobility in training chamber, 24h after fear conditioning , dose 0.18 mg   47139 Female
Male 10 10 10 10 14 10 14 10
FC_preCS_acu_0   acute group, percent immobility in altered context chamber, pre-cue , dose: control mg   47141 Female
Male 12 11 12 12 14 12 14 12
FC_preCS_acu_045   acute group, percent immobility in altered context chamber, pre-cue , dose: 0.045 mg   47142 Female
Male 10 10 10 9 14 10 14 10
FC_preCS_acu_09   acute group, percent immobility in altered context chamber, pre-cue , dose: 0.09 mg   47143 Female
Male 10 9 10 10 13 8 14 10
FC_preCS_acu_18   acute group, percent immobility in altered context chamber, pre-cue , dose: 0.18 mg   47144 Female
Male 10 10 10 10 14 10 14 10
FC_CS_acu_0   acute group, percent immobility in altered context chamber, cue , dose: control mg   47146 Female
Male 12 11 12 12 14 12 14 12
FC_CS_acu_045   acute group, percent immobility in altered context chamber, cue , dose: 0.045 mg   47147 Female
Male 10 10 10 9 14 10 14 10
FC_CS_acu_09   acute group, percent immobility in altered context chamber, cue , dose: 0.09 mg   47148 Female
Male 10 9 10 10 13 8 14 10
FC_CS_acu_18   acute group, percent immobility in altered context chamber, cue , dose: 0.18 mg   47149 Female
Male 10 10 10 10 14 10 14 10
FC_immediate_chr_0   chronic group, conditioning: immediate fear , control   47151 Female
Male 10 10 10 10 10 10 9 10
FC_immediate_chr_12   chronic group, conditioning: immediate fear , nicotine   47152 Female
Male 10 10 9 10 10 10 10 10
FC_context_chr_0   chronic group, conditioning: contextual fear , control   47156 Female
Male 10 10 10 10 10 10 9 10
FC_context_chr_12   chronic group, conditioning: contextual fear , nicotine   47157 Female
Male 10 10 9 10 10 10 10 10
FC_preCS_chr_0   chronic group, cued fear: pre-cue , control   47161 Female
Male 10 10 10 10 10 10 9 10
FC_preCS_chr_12   chronic group, cued fear: pre-cue , nicotine   47162 Female
Male 10 10 9 10 10 10 10 10
FC_CS_chr_0   chronic group, cued fear: cue , control   47166 Female
Male 10 10 10 10 10 10 9 10
FC_CS_chr_12   chronic group, cued fear: cue , nicotine   47167 Female
Male 10 10 9 10 10 10 10 10